NeuBase Therapeutics, Inc. Operating Lease Right-of-Use Assets
NeuBase Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $5.06 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-11-09
- 2023-09-30: Operating Lease, Right-of-Use Asset $5.06M.
- 2023-06-30: Operating Lease, Right-of-Use Asset $5.18M.
- 2023-03-31: Operating Lease, Right-of-Use Asset $5.30M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $5.41M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-09-30 | $5.06M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.18M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.30M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.41M 10-Q · filed 2023-11-09 |
| 2022-09-30 | $5.61M 10-QT · filed 2023-06-05 |
| 2022-06-30 | $5.75M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.88M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $5.84M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $5.95M 10-K · filed 2022-12-21 |
| 2021-06-30 | $6.05M 10-Q · filed 2021-08-13 |
| 2020-09-30 | $0.00 10-K · filed 2021-12-23 |